Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Pharmacol Biochem Behav. 2021 Mar 6;204:173169. doi: 10.1016/j.pbb.2021.173169

Table 2.

Characteristics of the stud y sample by type of prescription medication used extra-medically for sleep, and factors associated with type of prescription medication used extra-medically for sleep among the selected sample, National Survey of Drug Use and Health, 2015–2018.

Sedatives and/or Tranquilizers - only Prescription pain relievers - only Sedatives, tranquilizers and Prescription pain relievers Sedatives and/or Tranquilizers - only vs. Prescription pain relievers - only Sedatives and/or Tranquilizers - only vs. Sedatives, tranquilizers and Prescription pain relievers
% 95%CI % 95%CI % 95%CI RRR 95% CI aRRR 95% CI RRR 95% CI aRRR 95% CI
Gender
Female 55.9 53.1, 58.7 55.3 51.2, 59.0 49.5 42.6, 56.3 Ref Ref
Male 44.1 44.7, 50.6 44.7 40.6, 48.8 50.5 43.7, 57.4 1.0 0.8, 1.3 1.2 0.9, 1.5 1.3 0.9, 1.8 1.3 0.9, 1.8
Age
12 to 17
18 to 25 21.3 19.3, 23.3 24.4 21.6, 27.4 32.2 26.1, 39.0 1.3 1.0, 1.7 1.5 1.0, 2.1 2.6 1.5, 4.5 1.5 0.8, 2.8
26 to 34 23.7 21.5, 26.2 24.6 21.3, 28.3 23.5 18.4, 29.5 1.2 0.9, 1.6 1.3 0.9, 1.9 1.7 0.9, 3.1 1.2 0.6, 2.4
35 to 49 23.1 21.0, 25.4 22.8 20.2, 25.6 25.6 20.4, 31.6 1.1 0.9, 1.4 1.2 0.9, 1.6 1.9 1.1, 3.4 1.6 0.8, 2.9
50+ 31.9 28.8, 35.3 28.2 23.5, 33.5 18.7 11.8, 28.3 Ref Ref
Self-identified race-ethnicity
Non- Hispanic Whites 79.8 77.1, 82.1 69.7 65.4, 73.6 76.1 68.4, 82.4 Ref Ref
Non- Hispanic Blacks 4.5 3.6, 5.6 12.8 10.2, 16.0 7.9 5.5, 11.1 3.2 2.3, 4.6 3.1 2.1, 4.5 1.8 1.1, 2.9 1.9 1.2, 3.1
Hispanics 11.6 9.7, 13.8 11.1 9.2, 13.4 8.9 5.5, 14.2 1.1 0.8, 1.5 1.1 0.8, 1.5 0.8 0.5, 1.4 0.8 0.5, 1.5
Non-Hispanic Others 4.1 3.1, 5.5 6.4 4.5, 8.9 7.1 4.2, 11.9 1.8 1.0, 3.0 1.6 0.9, 2.8 1.8 1.0, 3.3 1.6 0.9, 2.9
Population density in area of residence
Rural 3.4 2.4, 4.6 5.2 3.9, 7.0 8.0 5.0, 12.6 1.5 0.9, 2.4 1.5 0.9, 2.5 2.9 1.6, 5.4 3.2 1.6, 6.1
Small metropolitan 40.8 37.1, 44.5 35.2 31.4, 39.2 45.9 39.1, 52.9 0.8 0.6, 1.0 0.8 0.6, 1.0 1.4 1.0, 1.9 1.4 0.9, 2.0
Large metropolitan 55.8 52.2, 59.6 59.6 55.4, 63.5 46.1 39.5, 52.8 Ref Ref
Poverty level
Living in poverty 13.2 11.5, 14.9 19.2 16.4, 22.3 19.7 14.9, 25.8 Ref Ref
Income up to 2 times federal poverty threshold 19.1 17.0, 21. 19.3 16.6, 22.4 21.2 15.8, 27.9 0.7 0.5, 1.0 0.8 0.5, 1.1 0.7 0.5, 1.2 0.8 0.5, 1.4
Income more than 2 times federal poverty threshold 67.6 65.0, 70.0 61.0 57.7, 64.4 58.2 51.7, 64.3 0.6 0.5, 0.8 0.7 0.6, 1.0 0.6 0.4, 0.8 0.8 0.5, 1.3
Health insurance coverage
No 13.3 11.6, 15.2 12.6 10.4, 15.2 16.6 11.7, 22.8 Ref Ref
Yes 86.7 84.8, 88.4 87.4 84.8, 89.6 83.4 77.2, 88.3 1.1 0.8, 1.4 1.1 0.9, 1.5 0.8 0.5, 1.2 1.0 0.6, 1.7
Past 12-months serious psychological distress
No 66.6 63.9, 69.2 60.1 56.2, 63.8 49.5 42.0, 57.1 Ref Ref
Yes 33.4 30.8, 36.1 40.0 36.3, 43.8 50.5 42.9, 57.9 1.3 1.1, 1.6 1.3 1.1, 1.6 2.0 1.5, 2.8 1.7 1.1, 2.6
Self-reported health status
Excellent/good 85.0 82.9, 86.9 79.3 74.6, 83.3 81.9 76.0, 86.6 Ref Ref
Fair/Poor 14.9 13.1, 17.1 20.7 16.7, 25.4 18.1 13.4, 23.9 1.5 1.1, 2.0 1.5 1.1, 2.1 1.3 0.8, 1.9 1.2 0.8, 1.9
Past 12-months tobacco use
No use 42.3 38.7, 46.0 45.3 40.7, 49.9 28.8 22.4, 36.2 Ref Ref
Use, no evidence of use disorder 36.3 33.5, 39.2 31.0 27.3, 35.1 43.7 36.7, 51.0 0.8 0.6, 1.0 0.6 0.5, 0.8 1.8 1.2, 2.6 1.0 0.7, 1.6
Nicotine dependence 21.4 18.8, 24.3 23.7 20.5, 27.4 27.5 20.5, 35.7 1.0 0.8, 1.4 0.9 0.6, 1.2 1.9 1.1, 3.1 1.0 0.6, 1.6
Past 12-months alcohol use
No use 14.2 11.7, 17.0 13.2 10.2, 16.8 8.4 4.9, 14.0 Ref Ref
Use, no evidence of use disorder 62.7 59.4, 66.0 60.1 55.1, 64.9 57.7 49.5, 65.5 1.0 0.8, 1.4 1.2 0.8, 1.6 1.5 0.8, 2.9 1.6 0.8, 3.1
Alcohol abuse or dependence 23.1 20.3, 26.2 26.7 22.4, 31.5 33.9 28.1, 40.2 1.2 0.9, 1.8 1.5 1.0, 2.2 2.5 1.4, 4.3 2.0 1.1, 3.7
Past 12-months cannabis use
No use 51.1 47.9, 54.1 49.8 45.1, 54.6 34.8 28.6, 41.5 Ref Ref
Use, no evidence of use disorder 39.6 36.5, 42.8 41.4 36.8, 46.2 49.1 42.9, 55.3 1.1 0.8, 1.4 1.1 0.8, 1.5 1.8 1.3, 2.6 1.3 0.9, 1.9
Cannabis abuse or dependence 9.3 7.9, 10.9 8.8 7.0, 11.0 16.1 12.6, 20.4 1.0 0.7, 1.3 0.9 0.6, 1.3 2.5 1.7, 3.8 1.3 0.9, 2.1
Past 12-months use of other drugs
No 72.4 69.1, 75.4 75.8 72.2, 79.1 56.0 49.4, 62.5 Ref Ref
Use, no evidence of use disorder 11.6 9.6, 13.9 11.2 8.5, 14.5 13.9 10.1, 18.8 0.9 0.6, 1.4 0.9 0.6, 1.3 1.6 1.0, 2.3 1.3 0.8, 1.9
Abuse or dependence 16.0 13.9, 18.4 13.0 10.4, 16.1 30.1 25.1, 35.6 0.8 0.6, 1.1 0.7 0.5, 0.9 2.4 1.8, 3.3 1.6 1.1, 2.2
Year of survey
2015 24.9 22.5, 27.7 28.4 24.3, 32.9 26.4 20.4, 33.3 Ref Ref
2016 27.4 24.4, 30.6 24.3 21.0, 27.9 25.1 18.2, 33.6 0.8 0.6, 1.1 0.8 0.6, 1.1 0.9 0.6, 1.3 0.9 0.6, 1.3
2017 24.7 22.2, 27.4 24.4 20.7, 28.4 27.0 19.9, 35.6 0.9 0.6, 1.2 0.9 0.6, 1.2 1.0 0.6, 1.6 1.0 0.7, 1.6
2018 23.0 20.8, 25.3 22.9 19.4, 26.8 21.5 15.3, 29.4 0.9 0.7, 1.2 0.9 0.6, 1.2 0.9 0.5, 1.4 0.8 0.5, 1.5

Notes: RRR = Relative Risk Ratio; aRRR = adjusted Relative Risk Ratio.